Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,539 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Relationship Between Anti-DFS70 Autoantibodies and Oxidative Stress.
Krzemień P, Kasperczyk S, Banach M, Kasperczyk A, Dobrakowski M, Tomasik T, Windak A, Mastej M, Catapano A, Ray KK, Mikhailidis DP, Toth PP, Howard G, Lip GY, Tomaszewski M, Charchar FJ, Sattar N, Williams B, MacDonald TM, Penson PE, Jóźwiak JJ. Krzemień P, et al. Among authors: sattar n. Biomark Insights. 2022 Jan 30;17:11772719211066791. doi: 10.1177/11772719211066791. eCollection 2022. Biomark Insights. 2022. PMID: 35125863 Free PMC article.
Strikingly low circulating CRP concentrations in ultramarathon runners independent of markers of adiposity: how low can you go?
Tomaszewski M, Charchar FJ, Przybycin M, Crawford L, Wallace AM, Gosek K, Lowe GD, Zukowska-Szczechowska E, Grzeszczak W, Sattar N, Dominiczak AF. Tomaszewski M, et al. Among authors: sattar n. Arterioscler Thromb Vasc Biol. 2003 Sep 1;23(9):1640-4. doi: 10.1161/01.ATV.0000087036.75849.0B. Epub 2003 Jul 17. Arterioscler Thromb Vasc Biol. 2003. PMID: 12869354
Serum C-reactive protein and lipids in ultra-Marathon runners.
Tomaszewski M, Charchar FJ, Crawford L, Zukowska-Sczechowska E, Grzeszczak W, Sattar N, Dominiczak AF. Tomaszewski M, et al. Among authors: sattar n. Am J Cardiol. 2004 Jul 1;94(1):125-6. doi: 10.1016/j.amjcard.2004.03.043. Am J Cardiol. 2004. PMID: 15219523
Glomerular hyperfiltration: a new marker of metabolic risk.
Tomaszewski M, Charchar FJ, Maric C, McClure J, Crawford L, Grzeszczak W, Sattar N, Zukowska-Szczechowska E, Dominiczak AF. Tomaszewski M, et al. Among authors: sattar n. Kidney Int. 2007 Apr;71(8):816-21. doi: 10.1038/sj.ki.5002160. Epub 2007 Feb 28. Kidney Int. 2007. PMID: 17332732 Free article.
The relation of rapid changes in obesity measures to lipid profile - insights from a nationwide metabolic health survey in 444 Polish cities.
Kaess BM, Jóźwiak J, Nelson CP, Lukas W, Mastej M, Windak A, Tomasik T, Grzeszczak W, Tykarski A, Gąsowski J, Ślęzak-Prochazka I, Ślęzak A, Charchar FJ, Sattar N, Thompson JR, Samani NJ, Tomaszewski M. Kaess BM, et al. Among authors: sattar n. PLoS One. 2014 Jan 31;9(1):e86837. doi: 10.1371/journal.pone.0086837. eCollection 2014. PLoS One. 2014. PMID: 24497983 Free PMC article.
Systematic Review and Network Meta-Analysis on the Efficacy of Evolocumab and Other Therapies for the Management of Lipid Levels in Hyperlipidemia.
Toth PP, Worthy G, Gandra SR, Sattar N, Bray S, Cheng LI, Bridges I, Worth GM, Dent R, Forbes CA, Deshpande S, Ross J, Kleijnen J, Stroes ESG. Toth PP, et al. Among authors: sattar n. J Am Heart Assoc. 2017 Oct 2;6(10):e005367. doi: 10.1161/JAHA.116.005367. J Am Heart Assoc. 2017. PMID: 28971955 Free PMC article. Review.
Effect of Evolocumab on Lipoprotein Particles.
Toth PP, Sattar N, Blom DJ, Martin SS, Jones SR, Monsalvo ML, Elliott M, Davis M, Somaratne R, Preiss D. Toth PP, et al. Among authors: sattar n. Am J Cardiol. 2018 Feb 1;121(3):308-314. doi: 10.1016/j.amjcard.2017.10.028. Epub 2017 Nov 8. Am J Cardiol. 2018. PMID: 29221604 Clinical Trial.
1,539 results